Regular ArticleCell-Type Specificity of l-Leucyl l-Leucine Methyl Ester
-
Add time:08/28/2019 Source:sciencedirect.com
l-Leucyl l-leucine methyl ester (LeuLeuOMe) is a lysosomotropic agent which is converted to a membranolytic compound by dipeptidyl peptidase I and kills human leukocytes such as CD8+ T cells and monocytes but not B cells. The reagent has also been used in mice on the assumption that the cell-type specificity to murine leukocytes is the same as that to human leukocytes. During study on the effect of LeuLeuOMe on antigen-driven IL-2 production using murine splenocytes as antigen-presenting cells, however, we noticed that murine B cells were sensitive to LeuLeuOMe. We therefore examined the cell-type specificity using murine splenocytes and peritoneal macrophages. Flow cytometric analysis revealed that the most sensitive cells to LeuLeuOMe were CD8+ cells and that CD19+ cells (B cells) were as sensitive as CD3+ cells (T cells). Murine splenic B cells, which were either positively or negatively sorted with a cell sorter, were also sensitive to LeuLeuOMe, whereas human peripheral blood B cells, which were positively sorted, were not. Peritoneal macrophages were the most insensitive to LeuLeuOMe. Thus, this study demonstrated that the cell-type specificity to murine leukocytes is different from that to human leukocytes.
We also recommend Trading Suppliers and Manufacturers of leucyl-leucine-methyl ester (cas 13022-42-9). Pls Click Website Link as below: cas 13022-42-9 suppliers
Prev:Croconic acid: An absorber in the Venus clouds?
Next:Regular ArticleSynthesis of Caged Compounds of L-Leucyl-L-Leucine Methyl Ester, an Apoptosis Inducer, and Their Cytotoxic Activity) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Clinical ResearchAntiviral Responses following L-Leucyl-L-Leucine Methyl Esther (LLME)-Treated Lymphocyte Infusions: Graft-versus-Infection without Graft-versus-Host Disease09/05/2019
- Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk09/04/2019
- Treatment of donor cells with l-leucyl-l-leucine methyl ester prevents induction of graft-vs-host-like reaction in [lprlpr → +/+] chimera09/03/2019
- Regular ArticleSynthesis and Cytotoxic Studies of 5-O-(β–Glucopyranosyl)-2-nitrobenzyl Cagedl-Leucyl-l-Leucine Methyl Ester with Increased Solubility in PBS Containing 1% DMSO☆☆☆09/02/2019
- Original ArticleEffects of the Immunosuppressive Dipeptide L-Leucyl-L-Leucine O-Methyl Ester on Epidermal Langerhans Cells09/01/2019
- Design, synthesis, photochemical properties and cytotoxic activities of water-Soluble caged l-Leucyl-l-leucine methyl esters that control apoptosis of immune cells08/31/2019
- Research paperEpstein-Barr virus-induced transformation of human B lymphocytes: the effect of l-leucyl-l-leucine methyl ester on inhibitory T cell populations08/30/2019
- Regular ArticleSynthesis of Caged Compounds of L-Leucyl-L-Leucine Methyl Ester, an Apoptosis Inducer, and Their Cytotoxic Activity08/29/2019


